Update shared on 09 Dec 2025
Fair value Decreased 1.18%Analysts have trimmed their price target for PETRONAS Chemicals Group Berhad by about 1% to roughly RM3.43. They cited slightly softer long term revenue growth and margin expectations despite improved valuation multiples, similar to how they see benefits of scale taking time to materialize in other sector consolidations.
Analyst Commentary
Recent commentary on PETRONAS Chemicals Group Berhad highlights a mixed but generally balanced outlook, with analysts weighing near term cyclical pressures against the group’s longer term strategic positioning and cash generation profile.
Bullish Takeaways
- Bullish analysts argue that the modest target price trim largely reflects fine tuning of long term growth and margin inputs rather than a fundamental change in the investment case, keeping the valuation anchored near historical trough multiples.
- They note that the company’s scale, integrated asset base, and linkages to PETRONAS provide cost advantages that should become more evident as industry demand gradually normalizes, supporting an eventual recovery in earnings power.
- Some see upside from disciplined capital allocation, with a focus on high returning debottlenecking projects and specialty product mix shifts that could lift returns on capital over the medium term.
- There is a view that current market expectations may underappreciate the operating leverage to even a modest improvement in regional chemical spreads, which could drive faster than modeled earnings growth once the cycle turns.
Bearish Takeaways
- Bearish analysts emphasize that weaker long term volume and margin assumptions reflect a more competitive global supply landscape, limiting the pace at which PETRONAS Chemicals can expand profitability from current levels.
- They are cautious that the benefits of scale and integration, while real, may take longer to fully materialize given uneven demand recovery and potential overcapacity in some commodity product segments.
- Concerns persist that execution risk around portfolio upgrades and new projects could weigh on free cash flow if returns do not ramp quickly enough to offset softer base business economics.
- Some also highlight that, despite improved valuation multiples, the share price could remain range bound if catalysts around stronger pricing, higher utilization, or clearer capital return policies do not emerge in the near term.
Valuation Changes
- Fair Value: Trimmed slightly from MYR 3.47 to MYR 3.43, reflecting more conservative long term assumptions.
- Discount Rate: Reduced marginally from 9.54% to 9.49%, implying a slightly lower perceived risk profile or funding cost.
- Revenue Growth: Lowered modestly from 4.35% to 4.09% per year, incorporating a softer long term demand outlook.
- Net Profit Margin: Reduced from 6.89% to 6.46%, indicating expectations of somewhat weaker profitability over the forecast horizon.
- Future P/E: Raised from 16.46x to 17.46x, suggesting a small upward adjustment to the valuation multiple applied to forward earnings.
Have other thoughts on PETRONAS Chemicals Group Berhad?
Create your own narrative on this stock, and estimate its Fair Value using our Valuator tool.
Create NarrativeDisclaimer
AnalystConsensusTarget is a tool utilizing a Large Language Model (LLM) that ingests data on consensus price targets, forecasted revenue and earnings figures, as well as the transcripts of earnings calls to produce qualitative analysis. The narratives produced by AnalystConsensusTarget are general in nature and are based solely on analyst data and publicly-available material published by the respective companies. These scenarios are not indicative of the company's future performance and are exploratory in nature. Simply Wall St has no position in the company(s) mentioned. Simply Wall St may provide the securities issuer or related entities with website advertising services for a fee, on an arm's length basis. These relationships have no impact on the way we conduct our business, the content we host, or how our content is served to users. The price targets and estimates used are consensus data, and do not constitute a recommendation to buy or sell any stock, and they do not take account of your objectives, or your financial situation. Note that AnalystConsensusTarget's analysis may not factor in the latest price-sensitive company announcements or qualitative material.
